Abstracts Archive - Page 530 of 1683 - ATC Abstracts

2020 American Transplant Congress
Geographic Distribution of End-Stage Renal Disease in the US: The First Description of an “ESRD Belt”
R. D. Reed¹, H. Qu¹, P. A. MacLennan¹, M. N. Mustian¹, D. Anderson¹, A. C. Kale¹, B. J. Orandi¹, B. A. Shelton¹, V. Kumar², M. J. Hanaway¹, J. E. Locke¹
¹Surgery, University of Alabama at Birmingham, Birmingham, AL, ²Medicine, University of Alabama at Birmingham, Birmingham, AL
*Purpose: Previous research has demonstrated that population health is associated with organ supply and transplantation; this is particularly true in the southeastern United States, which…
2020 American Transplant Congress
Improvements in Organ Donation: Riding the Coattails of a National Tragedy
D. Goldberg¹, R. Lynch²
¹Medicine, University of Miami, Miami, FL, ²Emory University, Atlanta, GA
*Purpose: The US organ donation system has received attention from the highest levels of government. It has been debated whether increased donation is attributable solely…
2020 American Transplant Congress
Impact of County Health Rankings on Nationwide Liver Transplant Outcomes
S. K. Niazi¹, E. Vargas², A. Spaulding³, J. Crook⁴, A. P. Keaveny⁵, T. Schneekloth⁶, T. Rummans⁷, C. Taner⁵
¹Psychiatry & Psychology; Transplantation, Mayo Clinic, Jacksonville, FL, ²Heath Services Research, Mayo Clinic, Jacksonville, FL, ³Health Services Research, Mayo Clinic, Jacksonville, FL, ⁴Health Sciences Research, Mayo Clinic, Jacksonville, FL, ⁵Transplantation, Mayo Clinic, Jacksonville, FL, ⁶Psychiatry & Psychology, Mayo Clinic, Rochester, MN, ⁷Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL
*Purpose: We examined the impact of social determinants of health (SDOH) in LT recipients’ counties of residence and their associations with long-term patient and graft…
2020 American Transplant Congress
The Heart of the Matter: The Impact of the 2018 Heart Allocation Policy at a Single Organ Procurement Organization
A. J. Boyer, J. B. Nave, C. A. Hostetler, C. C. Muse, R. A. Squires, J. P. Orlowski
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: In 2018, allocation policy changed with the goal of lowering waitlist mortality by increasing access to donor hearts. We sought to describe the impact…
2020 American Transplant Congress
Estimating the Potential Pool of Uncontrolled DCD Donors in the United States
B. J. Boyarsky, K. R. Jackson, A. B. Kernodle, J. V. Sakran, J. M. Garonzik Wang, S. E. Ottmann, D. L. Segev
Johns Hopkins, Baltimore, MD
*Purpose: In contrast to donation after brain death (DBD), donation after circulatory death (DCD) involves recovery of organs from people with devastating neurologic injury who…
2020 American Transplant Congress
No Correlation Between Program-Specific Report Performance of Different Organs at the Same Center
A. Massie¹, N. Salkowski², D. Zaun², J. Snyder², D. Segev¹
¹Johns Hopkins, Baltimore, MD, ²SRTR, Minneapolis, MN
*Purpose: Transplant programs which have too many early graft failures, as determined by the SRTR Program-Specific Reports (PSRs) risk decreased patient volume, regulatory sanction, and…
2020 American Transplant Congress
Survey of Public Attitudes Towards Imminent Death Donation in the United States
L. Washburn¹, T. Galvan¹, P. Moolchandani¹, S. Rath¹, R. Ackah², S. Parsons³, R. P. Brown³, E. Ranova³, M. Goss⁴, A. Rana¹, J. A. Goss¹
¹Division of Abdominal Transplantation, Baylor College of Medicine, Houston, TX, ²Department of Surgery, Ohio State University, Columbus, OH, ³Rice University, Houston, TX, ⁴Department of Bioethics, Columbia University, New York, NY
*Purpose: Imminent Death Donation (IDD) has been proposed as a method to increase the number of high-quality organs available for transplant. Although IDD was ethically…
2020 American Transplant Congress
Prevalence, Prognosis and Predictors of Neurological Complications after Heart Transplantation
C. Caraviello, D. Harsanyi, L. Trevizan, F. Bacal, S. Mangini
Cardiology, Hospital Israelita Albert Einstein, São Paulo, Brazil
*Purpose: Heart transplantation (HT) is considered the gold-standard treatment for end-stage heart failure. In spite of its innumerous benefits, this therapy still involves complications. Among…
2020 American Transplant Congress
Taking it to the Max: Extremely Low LDL May Provide Benefit for Prevention of Cardiac Allograft Vasculopathy
R. Lee¹, E. J. Henricksen¹, Y. Moayedi², K. Y. Feng³, J. Han³, W. Yang⁴, R. Imai¹, J. J. Teuteberg⁴, K. K. Khush⁴
¹Pharmacy, Stanford Health Care, Stanford, CA, ²University Health Network, Toronto, ON, Canada, ³Medicine, Stanford University, Stanford, CA, ⁴Cardiac Transplant, Stanford University, Stanford, CA
*Purpose: Routine use of statins is the only Class I ISHLT recommendation in heart transplantation (HT) to reduce cardiac allograft vasculopathy (CAV) and improve survival.…
2020 American Transplant Congress
Current Status of Pre-Transplant Mortality in Pediatric Organ Transplantation
G. Mazariegos¹, E. Hsu², .. OPTN Pediatric Committee³
¹UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, ²Seattle Children's, Seattle, WA, ³UNOS, Richmond, VA
*Purpose: Although NOTA states that organ allocation policy must recognize differences between children and adults, and adopt criteria, policies, and procedures that address the unique…